OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Sarfaraz K. Niazi
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1556-1556
Open Access | Times Cited: 5
Sarfaraz K. Niazi
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1556-1556
Open Access | Times Cited: 5
Showing 5 citing articles:
Endotypes of severe neutrophilic and eosinophilic asthma from multi‐omics integration of U‐BIOPRED sputum samples
Nazanin Zounemat Kermani, Chuanxing Li, Ali Versi, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 3
Nazanin Zounemat Kermani, Chuanxing Li, Ali Versi, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 3
Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs—Protocols and Advice for the FDA to Meet the ALS Act Vision
Sarfaraz K. Niazi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10211-10211
Open Access | Times Cited: 1
Sarfaraz K. Niazi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10211-10211
Open Access | Times Cited: 1
Advice to the US FDA to Allow US Pharmacopeia to Create Biological Product Specifications (BPS) to Remove Side-by-Side Analytical Comparisons of Biosimilars with Reference Products
Sarfaraz K. Niazi
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1013-1013
Open Access
Sarfaraz K. Niazi
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1013-1013
Open Access
Evolution of International Standards for the Approval of Biosimilars: A Path to Flexibilities
José G. Ramírez, Claudia P. Vaca G
Topics in medicinal chemistry (2024)
Closed Access
José G. Ramírez, Claudia P. Vaca G
Topics in medicinal chemistry (2024)
Closed Access
A timely recommendation to the european medicines agency and the FDA on rationalizing comparative clinical efficacy testing of biosimilars
Sarfaraz K. Niazi
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Sarfaraz K. Niazi
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
